Hearing Loss Clinical Trials
Here are the 6 most popular medical studies for hearing loss
Cholesterol + Antioxidants for Smith-Lemli-Opitz Syndrome
This trial is testing a treatment for patients with a rare genetic disease called Smith-Lemli-Opitz syndrome. The treatment involves giving the patients cholesterol and antioxidant medication, and then carefully monitoring them with regular clinic visits and lab tests. Once a year, the patients also undergo a series of tests under anesthesia, to check for any progression of their disease.
Ringer's Lactate Injection for Hearing Loss
This trial is testing whether injecting Ringer's Lactate into the ear via a pressure equalising tube can prevent tinnitus, vestibular dysfunction and hearing loss in patients undergoing platinum based chemotherapy treatment.
Popular filter options for hearing loss trials
Sensorineural Hearing Loss Clinical Trials
View 72 Sensorineural Hearing Loss medical studies.
Behavioral Intervention
Music Training for Cochlear Implant Users
This trial will study how people who have gotten cochlear implants react to music. It will help researchers understand how music appreciation works and what role it plays in quality of life.
Behavioral Intervention
Parent Training for Childhood Hearing Loss
This trial will test an adapted version of an evidence-based parent training intervention to help parents of young deaf and hard of hearing children, in order to prevent costly long-term behavioral problems.
Genetic Testing
Usual Care + Exome Seq for Epilepsy
This trial will compare first-line exome sequencing to usual care, as well as participant pre-visit preparation to no pre-visit preparation, in order to determine the net impact of diagnostic results and secondary findings.
Behavioural Intervention
Individualized Hearing Aid Fitting for Hearing Loss
This trial aims to create a better hearing aid fitting process by developing a toolset that guides signal processing based on the individual auditory and cognitive abilities of the patient. The clinical trial portion of the project will validate the use of the toolset by comparing outcomes of patients fit with the toolset to those fit using the current standard of care.
SPHL Clinical Trials
View 62 SPHL medical studies.
Behavioral Intervention
Music Training for Cochlear Implant Users
This trial will study how people who have gotten cochlear implants react to music. It will help researchers understand how music appreciation works and what role it plays in quality of life.
Behavioral Intervention
Parent Training for Childhood Hearing Loss
This trial will test an adapted version of an evidence-based parent training intervention to help parents of young deaf and hard of hearing children, in order to prevent costly long-term behavioral problems.
Genetic Testing
Usual Care + Exome Seq for Epilepsy
This trial will compare first-line exome sequencing to usual care, as well as participant pre-visit preparation to no pre-visit preparation, in order to determine the net impact of diagnostic results and secondary findings.
Behavioural Intervention
Individualized Hearing Aid Fitting for Hearing Loss
This trial aims to create a better hearing aid fitting process by developing a toolset that guides signal processing based on the individual auditory and cognitive abilities of the patient. The clinical trial portion of the project will validate the use of the toolset by comparing outcomes of patients fit with the toolset to those fit using the current standard of care.
Hearing Loss Clinical Trials With No Placebo
View 99 hearing loss medical studies that do not have a placebo group.
Behavioral Intervention
Music Training for Cochlear Implant Users
This trial will study how people who have gotten cochlear implants react to music. It will help researchers understand how music appreciation works and what role it plays in quality of life.
Behavioral Intervention
Parent Training for Childhood Hearing Loss
This trial will test an adapted version of an evidence-based parent training intervention to help parents of young deaf and hard of hearing children, in order to prevent costly long-term behavioral problems.
Genetic Testing
Usual Care + Exome Seq for Epilepsy
This trial will compare first-line exome sequencing to usual care, as well as participant pre-visit preparation to no pre-visit preparation, in order to determine the net impact of diagnostic results and secondary findings.
Behavioural Intervention
Individualized Hearing Aid Fitting for Hearing Loss
This trial aims to create a better hearing aid fitting process by developing a toolset that guides signal processing based on the individual auditory and cognitive abilities of the patient. The clinical trial portion of the project will validate the use of the toolset by comparing outcomes of patients fit with the toolset to those fit using the current standard of care.
View More Hearing Loss Trials
See another 82 medical studies focused on hearing loss.
Frequently Asked Questions
Introduction to hearing loss
What are the top hospitals conducting hearing loss research?
When it comes to advancing the field of hearing loss research, several top hospitals are leading the way. The Vanderbilt University Medical Center in Nashville is at the forefront with five active clinical trials dedicated to understanding and treating hearing loss. With a total of 15 trials conducted since their first recorded trial in 2011, this institution's commitment to finding innovative solutions is evident. In Jackson, Mississippi, the University of Mississippi Medical Center has made significant contributions as well. Currently conducting four active hearing loss trials and having completed three previous studies since recording their first trial in 2019, they are actively working towards improving outcomes for individuals affected by hearing impairment.
Nationwide Children's Hospital in Columbus also plays a crucial role with its ongoing dedication to hearing loss research. They currently have four active clinical trials focused on better understanding this condition and find ways to offer effective interventions. Having started their initial trial only three years ago in 2018, they have quickly established themselves as key players in this field.
The University of Iowa in Iowa City joins these institutions' efforts by devoting resources to studying and addressing hearing loss through four ongoing clinical trials. Their involvement spans over sixteen years since initiating their first recorded trial on this subject back in 2004 resultingin fourteen various experiments held till date.Their work contributes significantly towards expanding our knowledge about this prevalent condition.
Lastly, we turn our attention to Los Angeles where the renowned University of Southern California is making notable strides against hearing loss with its current portfolio of four active clinical trials. Despite joining the pursuit most recently with its inaugural trial starting just last year (2020), they already make a meaningful impact alongside other established institutions across different regions.
Together, these hospitals represent beacons of hope for those experiencing auditory challenges while highlighting that advancements can occur from diverse locations across America By continuously pushing boundaries through groundbreaking research endeavors; we move closer towards improving prevention strategies,treatments,and ultimately enhancing quality life experiencesfor countless individuals struggling with hearing loss.
Which are the best cities for hearing loss clinical trials?
When it comes to hearing loss clinical trials, several cities emerge as top contenders for groundbreaking research. New york leads the pack with 16 active trials investigating treatments such as Valganciclovir, Ebselen, and Vagal Nerve Stimulation during Cochlear Implantation Surgery. Los Angeles follows closely behind with 11 ongoing studies focusing on interventions like Ebselen, Montelukast, and Voice lessons. Saint Louis showcases promising research with 10 active trials exploring treatment options ranging from chemoradiotherapy to Electrocochleography. Chicago also plays a significant role in hearing loss research with 9 active trials studying Hearing Aids, DTC Hearing Aid, and Valganciclovir among others. Lastly, Seattle contributes to the field with 8 active trials that investigate various interventions including Usual Care + Teletherapy (Low-Income) and DB-OTO - Dose Escalation. These cities provide individuals experiencing hearing loss access to cutting-edge clinical trials that pave the way for improved care and potential breakthroughs in this domain of healthcare.
Which are the top treatments for hearing loss being explored in clinical trials?
The quest to find effective treatments for hearing loss is ongoing, fueled by innovative research and clinical trials. Among the top contenders is an experimental treatment currently being explored in two active trials specifically focused on hearing loss. This pioneering therapy made its debut in 2012 and has since accumulated one all-time trial dedicated to addressing this challenging condition. As scientists continue their efforts, these clinical trials offer hope for advancements that could transform the lives of individuals affected by hearing loss worldwide.
What are the most recent clinical trials for hearing loss?
Recent clinical trials offer hope for individuals with hearing loss, as researchers explore innovative approaches to address this prevalent condition. One such trial focuses on the effectiveness of high-dose ORC-13661 in treating hearing loss, with promising results emerging from Phase 2 studies. Additionally, DB-OTO aims to evaluate dose escalation and its impact on mitigating hearing loss through combined Phase 1 and Phase 2 investigations. Cohort 2 is another study that investigates potential treatments for hearing loss across different phases of research. Furthermore, a noteworthy trial examines the efficacy of standard cisplatin-based chemotherapy when combined with sodium thiosulfate and mannitol for addressing hearing loss concerns. Finally, a Phase 4 trial explores statin usage as an intervention strategy against hearing loss. These diverse clinical trials demonstrate the commitment of scientists towards finding effective solutions for improving auditory health in those affected by hearing impairment.
What hearing loss clinical trials were recently completed?
Several clinical trials focusing on hearing loss have recently been completed, offering insights into potential treatments and advancements in this field. These trials include the study of a new medication sponsored by Stanford University School of Medicine, which concluded in November 2021. Another trial exploring innovative gene therapy for hearing loss was successfully conducted by the University of Miami Miller School of Medicine, concluding in September 2021. The completion of these trials brings us closer to better understanding and addressing hearing loss, providing hope for those affected by this condition.